Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer

被引:26
作者
Aldea, M. [1 ,2 ]
Clofent, J. [3 ]
Nunez de Arenas, C. [2 ]
Chamorro, M. [1 ]
Velasco, M. [1 ]
Berrendero, J. R. [5 ]
Navarro, C. [4 ]
Cuezva, J. M. [1 ,2 ]
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Dept Biol Mol, E-28049 Madrid, Spain
[2] Univ Autonoma Madrid, Hosp 12 Octubre, Inst Invest, E-28049 Madrid, Spain
[3] Hosp Univ Vigo, Serv Aparato Digestivo, Vigo 36200, Spain
[4] Hosp Univ Vigo, Dept Patol & Neuropatol, Vigo 36200, Spain
[5] Univ Autonoma Madrid, Dept Matemat, E-28049 Madrid, Spain
关键词
ATP synthase; Energy metabolism; Glycolysis; Mitochondria; Predictive markers; Prognostic markers; BETA-F1-ATPASE MESSENGER-RNA; PYRUVATE-KINASE; DISEASE PROGRESSION; CELL-DEATH; M2; METABOLISM; EXPRESSION; SURVIVAL; 5-FLUOROURACIL; TRANSLATION;
D O I
10.1016/j.canlet.2011.07.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A reverse phase protein microarray approach has been applied to quantify proteins of energy metabolism in normal and tumor biopsies of colorectal cancer (CRC) patients. The metabolic proteome of CRC specimens revealed a profound shift towards and enhanced glycolytic phenotype and concurrent mitochondrial alteration. The metabolic signature discriminated CRC patients with highly significant differences in overall and disease-free prognosis. The quantification of the bioenergetic signature of the tumor offers a relevant biomarker of CRC that could contribute in the handling of these patients. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:210 / 218
页数:9
相关论文
共 41 条
[1]
Cancer Abolishes the Tissue Type-Specific Differences in the Phenotype of Energetic Metabolism [J].
Acebo, Paloma ;
Giner, Daniel ;
Calvo, Piedad ;
Blanco-Rivero, Amaya ;
Ortega, Alvaro D. ;
Fernandez, Pedro L. ;
Roncador, Giovanna ;
Fernandez-Malave, Edgar ;
Chamorro, Margarita ;
Cuezva, Jose M. .
TRANSLATIONAL ONCOLOGY, 2009, 2 (03) :138-145
[2]
BRINCK U, 1994, VIRCHOWS ARCH, V424, P177
[3]
International Trends in Colorectal Cancer Incidence Rates [J].
Center, Melissa M. ;
Jemal, Ahmedin ;
Ward, Elizabeth .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (06) :1688-1694
[4]
Protein profiles associated with survival in lung adenocarcinoma [J].
Chen, GA ;
Gharib, TG ;
Wang, H ;
Huang, CC ;
Kuick, R ;
Thomas, DG ;
Shedden, KA ;
Misek, DE ;
Taylor, JMG ;
Giordano, TJ ;
Kardia, SLR ;
Iannettoni, MD ;
Yee, J ;
Hogg, PJ ;
Orringer, MB ;
Hanash, SM ;
Beer, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (23) :13537-13542
[5]
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth [J].
Christofk, Heather R. ;
Vander Heiden, Matthew G. ;
Harris, Marian H. ;
Ramanathan, Arvind ;
Gerszten, Robert E. ;
Wei, Ru ;
Fleming, Mark D. ;
Schreiber, Stuart L. ;
Cantley, Lewis C. .
NATURE, 2008, 452 (7184) :230-U74
[6]
The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis [J].
Cuezva, JM ;
Chen, G ;
Isidoro, A ;
Misek, DE ;
Hanash, SM ;
Beer, DG .
CARCINOGENESIS, 2004, 25 (07) :1157-1163
[7]
Cuezva JM, 2002, CANCER RES, V62, P6674
[8]
The tumor suppressor function of mitochondria: Translation into the clinics [J].
Cuezva, Jose M. ;
Ortega, Alvaro D. ;
Willers, Imke ;
Sanchez-Cenizo, Laura ;
Aldea, Marcos ;
Sanchez-Arago, Maria .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (12) :1145-1158
[9]
Colorectal cancer [J].
Cunningham, David ;
Atkin, Wendy ;
Lenz, Heinz-Josef ;
Lynch, Henry T. ;
Minsky, Bruce ;
Nordlinger, Bernard ;
Starling, Naureen .
LANCET, 2010, 375 (9719) :1030-1047
[10]
A conserved mechanism for controlling the translation of β-F1-ATPase mRNA between the fetal liver and cancer cells [J].
de Heredia, ML ;
Izquierdo, JM ;
Cuezva, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (10) :7430-7437